{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:46:53Z","timestamp":1785822413802,"version":"3.56.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-93482-8","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T18:50:08Z","timestamp":1742410208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comprehensive analysis of senescence-related genes identifies prognostic clusters with distinct characteristics in glioma"],"prefix":"10.1038","volume":"15","author":[{"given":"Wenyuan","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"issue":"2022","key":"93482_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics. CA Cancer J. Clin. 72(2022), 7\u201333. https:\/\/doi.org\/10.3322\/caac.21708 (2022).","journal-title":"CA Cancer J. Clin."},{"key":"93482_CR2","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.3390\/cancers13112621","volume":"13","author":"M Barcena-Varela","year":"2021","unstructured":"Barcena-Varela, M. & Lujambio, A. The endless sources of hepatocellular carcinoma heterogeneity. Cancers (Basel) 13, 2621. https:\/\/doi.org\/10.3390\/cancers13112621 (2021).","journal-title":"Cancers (Basel)"},{"key":"93482_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1083\/jcb.201708092","volume":"217","author":"D McHugh","year":"2018","unstructured":"McHugh, D. & Gil, J. Senescence and aging: Causes, consequences, and therapeutic avenues. J. Cell Biol. 217, 65\u201377. https:\/\/doi.org\/10.1083\/jcb.201708092 (2018).","journal-title":"J. Cell Biol."},{"key":"93482_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13041","volume":"18","author":"K Chatsirisupachai","year":"2019","unstructured":"Chatsirisupachai, K., Palmer, D., Ferreira, S. & de Magalh\u00e3es, J. P. A human tissue-specific transcriptomic analysis reveals a complex relationship between aging, cancer, and cellular senescence. Aging Cell 18, e13041. https:\/\/doi.org\/10.1111\/acel.13041 (2019).","journal-title":"Aging Cell"},{"key":"93482_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12744","volume":"17","author":"RF P\u00e9rez","year":"2018","unstructured":"P\u00e9rez, R. F., Tejedor, J. R., Bay\u00f3n, G. F., Fern\u00e1ndez, A. F. & Fraga, M. F. Distinct chromatin signatures of DNA hypomethylation in aging and cancer. Aging Cell 17, e12744. https:\/\/doi.org\/10.1111\/acel.12744 (2018).","journal-title":"Aging Cell"},{"key":"93482_CR6","doi-asserted-by":"publisher","unstructured":"Chatsirisupachai, K. An integrative analysis of the age-associated multi-omic landscape across cancers. Nat. Commun. 12(1), 2345. https:\/\/doi.org\/10.1038\/s41467-021-22560-y (2021).","DOI":"10.1038\/s41467-021-22560-y"},{"key":"93482_CR7","doi-asserted-by":"publisher","first-page":"110100","DOI":"10.1016\/j.celrep.2021.110100","volume":"37","author":"Y Shah","year":"2021","unstructured":"Shah, Y. et al. Pan-cancer analysis reveals molecular patterns associated with age. Cell Rep. 37, 110100. https:\/\/doi.org\/10.1016\/j.celrep.2021.110100 (2021).","journal-title":"Cell Rep."},{"key":"93482_CR8","unstructured":"Evaluating the impact of age on immune checkpoint therapy biomarker (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/34433020\/. Accessed August 1, 2024."},{"key":"93482_CR9","unstructured":"Hutchinson-Gilford Progeria Syndrome: A Premature Aging Disease (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/28660486\/. Accessed August 1, 2024."},{"key":"93482_CR10","unstructured":"Oncogene-induced senescence: From biology to therapy (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/32171687\/. Accessed August 1, 2024."},{"key":"93482_CR11","unstructured":"Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/33792717\/. Accessed August 1, 2024."},{"key":"93482_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: New dimensions. Cancer Discov. 12, 31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059 (2022).","journal-title":"Cancer Discov."},{"key":"93482_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","volume":"19","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Chinese Glioma Genome Atlas (CGGA): A comprehensive resource with functional genomic data from Chinese Glioma Patients. Genomics Proteomics Bioinform. 19, 1\u201312. https:\/\/doi.org\/10.1016\/j.gpb.2020.10.005 (2021).","journal-title":"Genomics Proteomics Bioinform."},{"key":"93482_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2017.24","volume":"4","author":"Z Zhao","year":"2017","unstructured":"Zhao, Z. et al. Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas. Sci. Data 4, 170024. https:\/\/doi.org\/10.1038\/sdata.2017.24 (2017).","journal-title":"Sci. Data"},{"key":"93482_CR15","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1101\/gr.165126.113","volume":"24","author":"Z-S Bao","year":"2014","unstructured":"Bao, Z.-S. et al. RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas. Genome Res. 24, 1765\u20131773. https:\/\/doi.org\/10.1101\/gr.165126.113 (2014).","journal-title":"Genome Res."},{"key":"93482_CR16","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.20892\/j.issn.2095-3941.2022.0469","volume":"19","author":"K Zhang","year":"2022","unstructured":"Zhang, K. et al. Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011\u20132017): A multicenter retrospective study from CGGA. Cancer Biol. Med. 19, 1460\u20131476. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2022.0469 (2022).","journal-title":"Cancer Biol. Med."},{"key":"93482_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/neuonc\/nou130","volume":"17","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping. Neuro Oncol 17, 282\u2013288. https:\/\/doi.org\/10.1093\/neuonc\/nou130 (2015).","journal-title":"Neuro Oncol"},{"key":"93482_CR18","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.nicl.2018.10.014","volume":"20","author":"X Liu","year":"2018","unstructured":"Liu, X. et al. A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas. Neuroimage Clin. 20, 1070\u20131077. https:\/\/doi.org\/10.1016\/j.nicl.2018.10.014 (2018).","journal-title":"Neuroimage Clin."},{"key":"93482_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/neuonc\/noab158","volume":"24","author":"OT Alhalabi","year":"2022","unstructured":"Alhalabi, O. T. et al. A novel patient stratification strategy to enhance the therapeutic efficacy of dasatinib in glioblastoma. Neuro Oncol 24, 39\u201351. https:\/\/doi.org\/10.1093\/neuonc\/noab158 (2022).","journal-title":"Neuro Oncol"},{"key":"93482_CR20","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572\u20131573. https:\/\/doi.org\/10.1093\/bioinformatics\/btq170 (2010).","journal-title":"Bioinformatics"},{"key":"93482_CR21","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"93482_CR22","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"93482_CR23","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes (n.d.)."},{"key":"93482_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: An R package for weighted correlation network analysis. BMC Bioinform. 9, 559. https:\/\/doi.org\/10.1186\/1471-2105-9-559 (2008).","journal-title":"BMC Bioinform."},{"key":"93482_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.861000","volume":"10","author":"S Liu","year":"2022","unstructured":"Liu, S. et al. Uncovering N4-acetylcytidine-related mRNA modification pattern and landscape of stemness and immunity in hepatocellular carcinoma. Front Cell Dev. Biol. 10, 861000. https:\/\/doi.org\/10.3389\/fcell.2022.861000 (2022).","journal-title":"Front Cell Dev. Biol."},{"key":"93482_CR26","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612. https:\/\/doi.org\/10.1038\/ncomms3612 (2013).","journal-title":"Nat. Commun."},{"key":"93482_CR27","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru, B. et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics 35, 4200\u20134202. https:\/\/doi.org\/10.1093\/bioinformatics\/btz210 (2019).","journal-title":"Bioinformatics"},{"key":"93482_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng, D. et al. IOBR: Multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures. Front Immunol. 12, 687975. https:\/\/doi.org\/10.3389\/fimmu.2021.687975 (2021).","journal-title":"Front Immunol."},{"key":"93482_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RGW Verhaak","year":"2010","unstructured":"Verhaak, R. G. W. et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98\u2013110. https:\/\/doi.org\/10.1016\/j.ccr.2009.12.020 (2010).","journal-title":"Cancer Cell"},{"key":"93482_CR30","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/s41591-024-02969-w","volume":"30","author":"R Drexler","year":"2024","unstructured":"Drexler, R. et al. A prognostic neural epigenetic signature in high-grade glioma. Nat. Med. 30, 1622\u20131635. https:\/\/doi.org\/10.1038\/s41591-024-02969-w (2024).","journal-title":"Nat. Med."},{"key":"93482_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/neuonc\/noy161","volume":"21","author":"W Wick","year":"2019","unstructured":"Wick, W. et al. N2M2 (NOA-20) phase I\/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma. Neuro Oncol 21, 95\u2013105. https:\/\/doi.org\/10.1093\/neuonc\/noy161 (2019).","journal-title":"Neuro Oncol"},{"key":"93482_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1158\/1078-0432.CCR-18-1580","volume":"25","author":"A Berberich","year":"2019","unstructured":"Berberich, A. et al. Targeting resistance against the MDM2 inhibitor RG7388 in glioblastoma cells by the MEK inhibitor trametinib. Clin. Cancer Res. 25, 253\u2013265. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1580 (2019).","journal-title":"Clin. Cancer Res."},{"key":"93482_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jocn.2017.10.041","volume":"47","author":"S Lam","year":"2018","unstructured":"Lam, S., Lin, Y., Zinn, P., Su, J. & Pan, I.-W. Patient and treatment factors associated with survival among pediatric glioblastoma patients: A Surveillance, Epidemiology, and End Results study. J. Clin. Neurosci. 47, 285\u2013293. https:\/\/doi.org\/10.1016\/j.jocn.2017.10.041 (2018).","journal-title":"J. Clin. Neurosci."},{"key":"93482_CR34","unstructured":"Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/30616404\/. Accessed August 1, 2024."},{"key":"93482_CR35","unstructured":"Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/27728804\/. Accessed August 1, 2024."},{"key":"93482_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan, D. & Weinberg, R. A. The Hallmarks of cancer. Cell 100, 57\u201370. https:\/\/doi.org\/10.1016\/S0092-8674(00)81683-9 (2000).","journal-title":"Cell"},{"key":"93482_CR37","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013 (2011).","journal-title":"Cell"},{"key":"93482_CR38","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/cac2.12591","volume":"44","author":"F Zhang","year":"2024","unstructured":"Zhang, F. et al. Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment. Cancer Commun. (Lond.) 44, 929\u2013966. https:\/\/doi.org\/10.1002\/cac2.12591 (2024).","journal-title":"Cancer Commun. (Lond.)"},{"key":"93482_CR39","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/bib\/bby026","volume":"20","author":"L Zhao","year":"2019","unstructured":"Zhao, L., Lee, V. H. F., Ng, M. K., Yan, H. & Bijlsma, M. F. Molecular subtyping of cancer: current status and moving toward clinical applications. Brief Bioinform. 20, 572\u2013584. https:\/\/doi.org\/10.1093\/bib\/bby026 (2019).","journal-title":"Brief Bioinform."},{"key":"93482_CR40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1757-2215-7-76","volume":"7","author":"M Takai","year":"2014","unstructured":"Takai, M. et al. The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer. J. Ovarian Res. 7, 76. https:\/\/doi.org\/10.1186\/1757-2215-7-76 (2014).","journal-title":"J. Ovarian Res."},{"key":"93482_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc3447","volume":"13","author":"BD Craene","year":"2013","unstructured":"Craene, B. D. & Berx, G. Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer 13, 97\u2013110. https:\/\/doi.org\/10.1038\/nrc3447 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"93482_CR42","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41419-021-03424-1","volume":"12","author":"A Xu","year":"2021","unstructured":"Xu, A. et al. Overexpressed P75CUX1 promotes EMT in glioma infiltration by activating \u03b2-catenin. Cell Death Dis. 12, 157. https:\/\/doi.org\/10.1038\/s41419-021-03424-1 (2021).","journal-title":"Cell Death Dis."},{"key":"93482_CR43","first-page":"523","volume":"36","author":"DS Jeevan","year":"2016","unstructured":"Jeevan, D. S., Cooper, J. B., Braun, A., Murali, R. & Jhanwar-Uniyal, M. Molecular pathways mediating metastases to the brain via epithelial-to-mesenchymal transition: Genes, proteins, and functional analysis. Anticancer Res. 36, 523\u2013532 (2016).","journal-title":"Anticancer Res."},{"key":"93482_CR44","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","volume":"7","author":"DS Shin","year":"2017","unstructured":"Shin, D. S. et al. Primary resistance to PD-1 blockade mediated by JAK1\/2 mutations. Cancer Discov. 7, 188\u2013201. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-1223 (2017).","journal-title":"Cancer Discov."},{"key":"93482_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34119","volume":"10","author":"P Feng","year":"2024","unstructured":"Feng, P., Liu, S., Yuan, G. & Pan, Y. Association of M2 macrophages with EMT in glioma identified through combination of multi-omics and machine learning. Heliyon 10, e34119. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34119 (2024).","journal-title":"Heliyon"},{"key":"93482_CR46","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature08712","volume":"463","author":"MS Carro","year":"2010","unstructured":"Carro, M. S. et al. The transcriptional network for mesenchymal transformation of brain tumors. Nature 463, 318\u2013325. https:\/\/doi.org\/10.1038\/nature08712 (2010).","journal-title":"Nature"},{"key":"93482_CR47","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s40425-019-0701-2","volume":"7","author":"D Wang","year":"2019","unstructured":"Wang, D. et al. Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1\/CEBPB\/NF-\u03baB signaling. J. Immunother. Cancer 7, 215. https:\/\/doi.org\/10.1186\/s40425-019-0701-2 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"93482_CR48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","volume":"28","author":"W Li","year":"2018","unstructured":"Li, W. et al. Aerobic glycolysis controls myeloid-derived suppressor cells and tumor immunity via a specific CEBPB isoform in triple-negative breast cancer. Cell Metab. 28, 87-103.e6. https:\/\/doi.org\/10.1016\/j.cmet.2018.04.022 (2018).","journal-title":"Cell Metab."},{"key":"93482_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20175","volume":"9","author":"Y Ren","year":"2023","unstructured":"Ren, Y., Guo, W. & Qiao, B. Abnormal expression of CEBPB promotes the progression of renal cell carcinoma through regulating the generation of IL-6. Heliyon 9, e20175. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20175 (2023).","journal-title":"Heliyon"},{"key":"93482_CR50","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1111\/odi.14879","volume":"30","author":"M Fu","year":"2024","unstructured":"Fu, M. et al. NAT10\/CEBPB\/vimentin signalling axis promotes adenoid cystic carcinoma malignant phenotypes in vitro. Oral Dis. 30, 4341\u20134355. https:\/\/doi.org\/10.1111\/odi.14879 (2024).","journal-title":"Oral Dis."},{"key":"93482_CR51","doi-asserted-by":"publisher","first-page":"djv306","DOI":"10.1093\/jnci\/djv306","volume":"108","author":"A Sartore-Bianchi","year":"2016","unstructured":"Sartore-Bianchi, A. et al. Sensitivity to entrectinib associated with a novel LMNA-NTRK1 gene fusion in metastatic colorectal cancer. J. Natl. Cancer Inst. 108, djv306. https:\/\/doi.org\/10.1093\/jnci\/djv306 (2016).","journal-title":"J. Natl. Cancer Inst."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93482-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93482-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93482-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T18:50:17Z","timestamp":1742410217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93482-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93482"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-93482-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"17 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All patients involved in this study have voluntarily signed the informed consent form, and this research project has been officially approved by the Ethics Committee of the Honghui Hospital Affiliated to Xi\u2019an Jiaotong University (Approval Number: 202406014). Throughout the research process, we have strictly adhered to the recommendations outlined in the Declaration of Helsinki, ensuring the legality and ethical integrity of the study. Furthermore, we solemnly commit to upholding the publication ethics policy of your esteemed journal and guarantee that all published research findings conform to the rigorous technical and ethical standards set by the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have provided their final approval for the version to be published, have agreed to the submission of the article to the journal, and have consented to assume responsibility for all aspects of the work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"9540"}}